Search

everythinglearnresearchcommunity

for

Search:↓

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

EBGS reduces platelet adhesion, potentially helping prevent blood clots.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

A patient with complete hair loss regrew all her hair using tofacitinib.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

These medications for BPH have known risks and may have new side effects.

The new compound may be a safer alternative to finasteride for prostate protection.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

The hydrogel significantly improves healing in diabetic wounds.

Caribine from traditional Chinese medicine may help treat hair loss.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Baricitinib is the most effective treatment for alopecia areata.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Isotretinoin and acitretin may effectively stabilize the hairline in patients with frontal fibrosing alopecia.

Forsythoside A may help treat hair loss by blocking specific channels.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.